| Ms Kathryn Mae Kovar, | |
|
108 Redstone Dr, Bismarck, ND 58503-1463 | |
| (701) 222-0753 | |
| Not Available |
| Full Name | Ms Kathryn Mae Kovar |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 108 Redstone Dr, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598795767 | NPI | - | NPPES |
| P00398986 | Other | KS | RR MEDICARE GROUP CQ2302 |
| 145396 | Other | KS | BCBS KS GROUP 110017 |
| 200420090A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R25020 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckenzie County Healthcare Systems Inc | Watford city, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mckenzie County Healthcare Systems Inc | 5890768006 | 21 |
News Archive
Amgen today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.
VOA News examines the implications of sequestration on the U.S. military's infectious disease research, noting "officials say the mandatory budget cuts ... will affect further testing of a potentially cutting-edge malaria vaccine, soon to be published."
Researchers at Columbia University Medical Center have found evidence in mice that, for some types of autism, gastrointestinal difficulties may originate from the same genetic changes that lead to the behavioral and social characteristics of the condition. The study was published in the Journal of Clinical Investigation.
Obesity guidelines recommend an initial weight loss goal of 5 to 10% of start weight to improve health. A recent study found that patients who received liraglutide 3.0 mg, combined with fewer calories and more physical activity, were more than twice as likely to achieve at least that level of weight loss, compared to patients on placebo who made similar lifestyle changes.
› Verified 9 days ago
| Entity Name | Mckenzie County Healthcare Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063420495 PECOS PAC ID: 5890768006 Enrollment ID: O20040817000016 |
News Archive
Amgen today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.
VOA News examines the implications of sequestration on the U.S. military's infectious disease research, noting "officials say the mandatory budget cuts ... will affect further testing of a potentially cutting-edge malaria vaccine, soon to be published."
Researchers at Columbia University Medical Center have found evidence in mice that, for some types of autism, gastrointestinal difficulties may originate from the same genetic changes that lead to the behavioral and social characteristics of the condition. The study was published in the Journal of Clinical Investigation.
Obesity guidelines recommend an initial weight loss goal of 5 to 10% of start weight to improve health. A recent study found that patients who received liraglutide 3.0 mg, combined with fewer calories and more physical activity, were more than twice as likely to achieve at least that level of weight loss, compared to patients on placebo who made similar lifestyle changes.
› Verified 9 days ago
| Entity Name | Bismarck Surgical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487814356 PECOS PAC ID: 6800855099 Enrollment ID: O20041004001040 |
News Archive
Amgen today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.
VOA News examines the implications of sequestration on the U.S. military's infectious disease research, noting "officials say the mandatory budget cuts ... will affect further testing of a potentially cutting-edge malaria vaccine, soon to be published."
Researchers at Columbia University Medical Center have found evidence in mice that, for some types of autism, gastrointestinal difficulties may originate from the same genetic changes that lead to the behavioral and social characteristics of the condition. The study was published in the Journal of Clinical Investigation.
Obesity guidelines recommend an initial weight loss goal of 5 to 10% of start weight to improve health. A recent study found that patients who received liraglutide 3.0 mg, combined with fewer calories and more physical activity, were more than twice as likely to achieve at least that level of weight loss, compared to patients on placebo who made similar lifestyle changes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kathryn Mae Kovar, 108 Redstone Dr, Bismarck, ND 58503-1463 Ph: (701) 222-0753 | Ms Kathryn Mae Kovar, 108 Redstone Dr, Bismarck, ND 58503-1463 Ph: (701) 222-0753 |
News Archive
Amgen today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.
VOA News examines the implications of sequestration on the U.S. military's infectious disease research, noting "officials say the mandatory budget cuts ... will affect further testing of a potentially cutting-edge malaria vaccine, soon to be published."
Researchers at Columbia University Medical Center have found evidence in mice that, for some types of autism, gastrointestinal difficulties may originate from the same genetic changes that lead to the behavioral and social characteristics of the condition. The study was published in the Journal of Clinical Investigation.
Obesity guidelines recommend an initial weight loss goal of 5 to 10% of start weight to improve health. A recent study found that patients who received liraglutide 3.0 mg, combined with fewer calories and more physical activity, were more than twice as likely to achieve at least that level of weight loss, compared to patients on placebo who made similar lifestyle changes.
› Verified 9 days ago
Rodney N Kraft, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Renee Christ, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Avenue, Bismarck, ND 58501 Phone: 701-530-7000 | |
Jamie L Hawk, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Kim E Geiger, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 900 E Broadway Avenue, Bismarck, ND 58501 Phone: 701-530-7000 Fax: 701-530-8842 | |
Rebekah Charchenko, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 | |
Brendin Michael Steiner, DNP Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 335 Willow Ln, Bismarck, ND 58504 Phone: 701-590-2762 | |
Donald Christopher Martin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000 |